Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

34.9K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
34.9K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

828
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
828
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

230
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230
Gastric Emptying01:16

Gastric Emptying

3.3K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
3.3K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

511
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
511
Glucose Transporters01:27

Glucose Transporters

27.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Smart biomaterials in the dimensional revolution of bioprinting: From 2D to 6D for advanced biomedical applications.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Mitochondrial Alterations and CKD.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Association between renin angiotensin system and cognitive outcomes over 15 years: The Look AHEAD study.

Journal of Alzheimer's disease : JAD·2026
Same author

Sphingosine-1-phosphate: Mechanisms and therapeutic potential in wound repair.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Increasing Obesity Severity Is Associated With Less Surgical Care in the United States.

Obesity (Silver Spring, Md.)·2026
Same author

Seasonal honey bee (Apis mellifera) physiology differentially impacts toxicity to pesticides used to control honey bee pests.

Journal of economic entomology·2026

相关实验视频

Updated: Jan 11, 2026

Roux-en-Y Gastric Bypass Operation in Rats
07:37

Roux-en-Y Gastric Bypass Operation in Rats

Published on: June 11, 2012

24.2K

鲁克斯-en-Y胃绕道与人类肠道葡萄糖摄入量增加有关.

Florina Corpodean1,2, Maryam Naseri3, Michael Kachmar1,2

  • 1Metamor Institute, Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.

Journal of the Endocrine Society
|November 17, 2025
PubMed
概括

人类的Roux-en-Y胃绕道 (RYGB) 不会增加Roux肢体的葡萄糖吸收,这与动物模型相反. 然而,在RYGB手术后的早期观察到结肠葡萄糖吸收的显著增加.

关键词:
鲁克斯的四肢是残酷的在Roux-en-Y的胃旁路术中.减肥手术 减肥手术是什么脱氧葡萄糖是一种脱氧葡萄糖.能源支出 能源支出胃绕道术是指胃绕道术.肠道适应 肠道适应肠道摄取葡萄糖的时间代谢性手术是代谢性手术.

更多相关视频

One-anastomosis Gastric Bypass OAGB in Rats
08:16

One-anastomosis Gastric Bypass OAGB in Rats

Published on: November 10, 2018

11.4K
A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
11:58

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

Published on: August 21, 2021

5.9K

相关实验视频

Last Updated: Jan 11, 2026

Roux-en-Y Gastric Bypass Operation in Rats
07:37

Roux-en-Y Gastric Bypass Operation in Rats

Published on: June 11, 2012

24.2K
One-anastomosis Gastric Bypass OAGB in Rats
08:16

One-anastomosis Gastric Bypass OAGB in Rats

Published on: November 10, 2018

11.4K
A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
11:58

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

Published on: August 21, 2021

5.9K

科学领域:

  • 腹部外科 腹部外科
  • 胃肠病学 胃肠病学
  • 代谢研究研究 代谢研究

背景情况:

  • 鲁克斯-en-Y胃绕道 (RYGB) 是一种具有已知的代谢益处的减肥手术.
  • 动物研究表明,Roux肢体在RYGB后的葡萄糖吸收增加可能有助于这些益处.
  • 关于RYGB对人类肠道葡萄糖吸收的影响的前性临床数据有限.

研究的目的:

  • 为了调查RYGB增加葡萄糖吸收在人类患者的鲁克斯肢体的假设.
  • 为了评估RYGB手术后肠道葡萄糖吸收的纵向变化.

主要方法:

  • 接受RYGB治疗的患者使用正子发射断层扫描/计算机断层扫描 (PET/CT) 成像进行了研究.
  • 影像检查是在手术前,手术后3个月和6个月进行的.
  • 对葡萄糖的标准化吸收值 (SUV) 在包括鲁克斯四肢和结肠在内的各种肠道段进行测量,用于纵向分析的脏正常化.

主要成果:

  • 尽管体重显著下降,但在RYGB后没有观察到Roux肢体葡萄糖吸收的增加.
  • 3个月后检测到结肠葡萄糖摄取量的显著增加 (眼皮,肝,西格结肠),并在6个月后维持 (P < .05).

结论:

  • 人类早期的术后RYGB与结肠的增加有关,而不是Roux肢体,葡萄糖吸收.
  • 在动物模型中观察到的Roux肢体葡萄糖吸收增加的机制似乎无法转化为人类生理学.
  • 在RYGB后肠道葡萄糖摄取量增加的临床意义需要进一步调查.